Clinical trial
Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and…
NCT00208182 · Creighton University, Other · Completed
Key facts
| NCT number | NCT00208182 |
|---|---|
| Title | Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma |
| Official title | Risperidone Monotherapy in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma: a Double-Blind, Placebo Controlled, Randomized Clinical Trial |
| Lead sponsor | Creighton University, Other |
| Collaborators | Janssen, LP Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Post-Traumatic Stress Disorder |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 20 |
| Start date | Jul 1, 2001 |
| Completion | Aug 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 10, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: